Sanchez, Lisa A.; Holdsworth, Mark; Bartel, Sylvia B. - In: PharmacoEconomics 18 (2000) 6, pp. 533-556
The serotonin 5-HT3 receptor antagonists or `setrons' have become the standard of care for the prevention of chemotherapy-induced emesis (CIE) and are first-line therapy for acute CIE in healthcare organisations worldwide. However, their superior efficacy versus standard antiemetics comes at a...